Amaç: Çalışma, majör depresif bozukluk (MDB) tanılı hastalar ile sağlıklı kontroller arasında tiroid hormon düzeylerinin karşılaştırılması ve tiroid hormonları normal sınırlarda olan hastaların cinsiyet ve klinik ölçeklerle ilişkilerinin değerlendirilmesini hedeflemektedir. Gereç ve Yöntemler: Bu çalışmaya üçüncü basamak bir psikiyatri hastanesinde yatan ve MDB tanısı konulan toplam 86 hasta ve benzer sosyodemografik özelliklere sahip 87 sağlıklı bireyden oluşan kontrol grubu dâhil edilmiştir. Klinik semptomlar, Çocuk Depresyon Derecelendirme Ölçeği [Children's Depression Rating Scale (CDRS)] ve Klinik Global İzlenim (KGİ) Ölçeği ile değerlendirilmiştir. Serum tiroid uyarıcı hormon [thyroid-stimulating hormone (TSH)], serbest tiroksin [free thyroxine (fT4)] ve serbest triiyodotironin [free triiodothyronine (fT3)] düzeylerini ölçmek için kan örnekleri alınmıştır. Bulgular: Çalışmamızda, hasta ile kontrol grubu arasında yaş (p=0,296) ve cinsiyet (p=0,952) arasında anlamlı farklılık saptanmamıştır. Hasta ve kontrol grubunda tiroid hormon seviyeleri normal aralıkta ölçülmüştür. MDB grubunda fT4 (p=0,003) ve fT3 (p<0,001) seviyeleri anlamlı şekilde düşük bulunurken, TSH (p=0,167) seviyeleri arasında fark saptanmamıştır. Cinsiyetin fT4 (Fcinsiyet=5,7, p=0,018) ve fT3 (Fcinsiyet=21,4, p<0,001) seviyeleri üzerinde etkisi olduğu belirlenmiştir. Kadınlarda gruplar arasında fT4 ve fT3 seviyelerindeki farklılıklar erkeklerden belirgindir. fT4 (r=-0,206, p=0,065) ve fT3 (r=-0,235, p=0,057) seviyeleri ile KGİ-S arasında zayıf düzeyde negatif yönde korelasyon bulunurken, TSH ile KGİ-S ve CDRS-total puanları arasında bir ilişki saptanmamıştır. Sonuç: MDB tanılı hastalarda tiroid hormon seviyeleri sağlıklı kontrollere göre daha düşük bulunması, tiroid hormonlarının depresyonun patolojik sürecine katkıda bulunabileceğini düşündürmektedir. Ayrıca, kadınlarda TSH düzeylerinin erkeklere göre daha yüksek, fT3 ve fT4 seviyelerinin ise daha düşük olması, depresyon ve cinsiyetin tiroid hormon düzeyleri üzerinde anlamlı etkileri olduğunu göstermektedir.
Anahtar Kelimeler: Ergen; depresyon; tiroid hormonları
Objective: This study aims to compare thyroid hormone levels between patients diagnosed with major depressive disorder (MDD) and healthy controls, and to evaluate the relationships between gender and clinical scales in patients with thyroid hormone levels within the normal range. Material and Methods: A total of 86 patients diagnosed with MDD and hospitalized in a tertiary psychiatry hospital, as well as a control group of 87 healthy individuals with similar sociodemographic characteristics, were included in the study. Clinical symptoms were assessed using the Children's Depression Rating Scale (CDRS) and the Clinical Global Impressions (CGI) scale. Blood samples were collected to measure serum thyroid-stimulating hormone (TSH), free thyroxine (fT4), and free triiodothyronine (fT3) levels. Results: In our study, no significant differences in age (p=0.296) or gender (p=0.952) were found between the patient and control groups. Thyroid hormone levels were normal in both groups. The MDD group showed significantly lower levels of fT4 (p=0.003) and fT3 (p<0.001), while no difference was detected in TSH levels (p=0.167). Gender was found to affect fT4 (Fgender=5.7, p=0.018) and fT3 levels (Fgender=21.4, p<0.001). The differences in fT4 and fT3 levels between groups are more pronounced in women than in men. A low-level negative correlation was found between fT4 (r=-0.206, p=0.065) and fT3 (r=-0.235, p=0.057) levels and CGI-S while no relationship was detected between TSH and CGI-S or CDRS scores. Conclusion: Thyroid hormone levels were found to be lower in patients with MDD compared to healthy controls, suggesting that thyroid hormones may contribute to the pathological process of depression. Additionally, TSH levels were higher in females than males, while fT3 and fT4 levels were lower, suggesting that depression and gender significantly affect thyroid hormone levels.
Keywords: Adolescent; depression; thyroid hormones
- WHO. Depression. 2019. Cited: 31.03.2023 [Link]
- American Psychiatric Association. Diagnostic and Statistical Manual of mental Disorders. 5th ed. USA: American Psychiatric Association; 2013. [Crossref]
- Shorey S, Ng ED, Wong CHJ. Global prevalence of depression and elevated depressive symptoms among adolescents: A systematic review and meta-analysis. Br J Clin Psychol. 2022;61(2):287-305. [Crossref] [PubMed]
- Scourfield J, Rice F, Thapar A, Harold GT, Martin N, McGuffin P. Depressive symptoms in children and adolescents: changing aetiological influences with development. J Child Psychol Psychiatry. 2003;44(7):968-76. [Crossref] [PubMed]
- Whybrow PC, Prange AJ Jr, Treadway CR. Mental changes accompanying thyroid gland dysfunction. A reappraisal using objective psychological measurement. Arch Gen Psychiatry. 1969;20(1):48-63. [Crossref] [PubMed]
- Williams GR. Neurodevelopmental and neurophysiological actions of thyroid hormone. J Neuroendocrinol. 2008;20(6):784-94. [Crossref] [PubMed]
- Zoeller RT, Rovet J. Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings. J Neuroendocrinol. 2004;16(10):809-18. [Crossref] [PubMed]
- Bauer M, Heinz A, Whybrow PC. Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain. Mol Psychiatry. 2002;7(2):140-56. [Crossref] [PubMed]
- Germain A, Kupfer DJ. Circadian rhythm disturbances in depression. Hum Psychopharmacol. 2008;23(7):571-85. [Crossref] [PubMed] [PMC]
- Yang R, Du X, Li Z, Zhao X, Lyu X, Ye G, et al. Association of subclinical hypothyroidism with anxiety symptom in young first-episode and drug-naïve patients with major depressive disorder. Front Psychiatry. 2022;13:920723. [Crossref] [PubMed] [PMC]
- Bathla M, Singh M, Relan P. Prevalence of anxiety and depressive symptoms among patients with hypothyroidism. Indian J Endocrinol Metab. 2016;20(4):468-74. [Crossref] [PubMed] [PMC]
- Zhao T, Chen BM, Zhao XM, Shan ZY. Subclinical hypothyroidism and depression: a meta-analysis. Transl Psychiatry. 2018;8(1):239. [Crossref] [PubMed] [PMC]
- Wildisen L, Del Giovane C, Moutzouri E, Beglinger S, Syrogiannouli L, Collet TH, et al. An individual participant data analysis of prospective cohort studies on the association between subclinical thyroid dysfunction and depressive symptoms. Sci Rep. 2020;10(1):19111. [Crossref] [PubMed] [PMC]
- Maes M, Meltzer HY, Cosyns P, Suy E, Schotte C. An evaluation of basal hypothalamic-pituitary-thyroid axis function in depression: results of a large-scaled and controlled study. Psychoneuroendocrinology. 1993;18(8):607-20. [Crossref] [PubMed]
- Kim EY, Kim SH, Rhee SJ, Huh I, Ha K, Kim J, et al. Relationship between thyroid-stimulating hormone levels and risk of depression among the general population with normal free T4 levels. Psychoneuroendocrinology. 2015;58:114-9. [Crossref] [PubMed]
- Zhou Y, Ma Y, Wu Q, Wang Q, Yang WFZ, Wang Y, et al. Comparison of thyroid hormone levels between patients with major depressive disorder and healthy individuals in China. Front Psychiatry. 2021;12:750749. [Crossref] [PubMed] [PMC]
- Osuna E, Baumgartner J, Walther A, Emery S, Albermann M, Baumgartner N, et al; Omega-3 study team. Investigating thyroid function and iodine status in adolescents with and without paediatric major depressive disorder. Br J Nutr. 2024;132(6):725-37. [Crossref] [PubMed] [PMC]
- Dorn LD, Burgess ES, Dichek HL, Putnam FW, Chrousos GP, Gold PW. Thyroid hormone concentrations in depressed and nondepressed adolescents: group differences and behavioral relations. J Am Acad Child Adolesc Psychiatry. 1996;35(3):299-306. [Crossref] [PubMed]
- Engum A, Bjøro T, Mykletun A, Dahl AA. An association between depression, anxiety and thyroid function--a clinical fact or an artefact? Acta Psychiatr Scand. 2002;106(1):27-34. [Crossref] [PubMed]
- Hirtz R, Hölling H, Grasemann C. Subclinical hypothyroidism and incident depression in adolescents and young adults: results from a nationwide representative prospective study. Thyroid. 2022;32(10):1169-77. [Crossref] [PubMed]
- Forman-Hoffman V, Philibert RA. Lower TSH and higher T4 levels are associated with current depressive syndrome in young adults. Acta Psychiatr Scand. 2006;114(2):132-9. [Crossref] [PubMed]
- Alşen Güney S, Baykara HB, İnal Emiroğlu N. Çocuklar için Depresyon Değerlendirme Ölçeği Revize Formunun Türk popülasyonundaki ergenlerde psikometrik özellikler [Psychometric properties of the Turkish adaptation of the Childrens Depression Rating Scale: revised in Turkish adolescents]. Alpha Psychiatry. 2018;19(Özel sayı 1):41-8. [Crossref]
- Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont). 2007;4(7):28-37. [PubMed] [PMC]
- Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H, et al. A children's global assessment scale (CGAS). Arch Gen Psychiatry. 1983;40(11):1228-31. [Crossref] [PubMed]
- Fam J, Rush AJ, Burt T, Chan ES, Siddiqui FJ, Assam PN, et al. Thyroid autoimmune antibodies and major depressive disorder in women. Ann Acad Med Singap. 2015;44(8):284-9. [Crossref] [PubMed]
- Premachandra BN, Kabir MA, Williams IK. Low T3 syndrome in psychiatric depression. J Endocrinol Invest. 2006;29(6):568-72. [Crossref] [PubMed]
- Fountoulakis KN, Kantartzis S, Siamouli M, Panagiotidis P, Kaprinis S, Iacovides A, et al. Peripheral thyroid dysfunction in depression. World J Biol Psychiatry. 2006;7(3):131-7. [Crossref] [PubMed]
- Roberts LM, Pattison H, Roalfe A, Franklyn J, Wilson S, Hobbs FD, et al. Is subclinical thyroid dysfunction in the elderly associated with depression or cognitive dysfunction? Ann Intern Med. 2006;145(8):573-81. [Crossref] [PubMed]
- Wei J, Sun G, Zhao L, Liu X, Lin D, Li T, et al. Hair thyroid hormones concentration in patients with depression changes with disease episodes in female Chinese. Psychiatry Res. 2014;220(1-2):251-3. [Crossref] [PubMed]
- Hatterer JA, Herbert J, Hidaka C, Roose SP, Gorman JM. CSF transthyretin in patients with depression. Am J Psychiatry. 1993;150(5):813-5. [Crossref] [PubMed]
- Foltyn W, Nowakowska-Zajdel E, Danikiewicz A, Brodziak A. Oś podwzgórze-przysadka-tarczyca w depresji [Hypothalamic-pituitary-thyroid axis in depression]. Psychiatr Pol. 2002;36(2):281-92. Polish. [PubMed]
- Flach FF, Celian CI, Rawson RW. Treatment of psychiatric disorders with triiodothyronine. Am J Psychiatry. 1958;114(9):841-2. [Crossref] [PubMed]
- Parmentier T, Sienaert P. The use of triiodothyronine (T3) in the treatment of bipolar depression: a review of the literature. J Affect Disord. 2018;229:410-4. [Crossref] [PubMed]
- Garlow SJ, Dunlop BW, Ninan PT, Nemeroff CB. The combination of triiodothyronine (T3) and sertraline is not superior to sertraline monotherapy in the treatment of major depressive disorder. J Psychiatr Res. 2012;46(11):1406-13. [Crossref] [PubMed] [PMC]
- Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489-99. [Crossref] [PubMed]
.: Process List